Search Results - "BRUSASCO, V"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD by BRUSASCO, V, HODDER, R, MIRAVITLLES, M, KORDUCKI, L, TOWSE, L, KESTEN, S

    Published in Thorax (01-05-2003)
    “…A study was undertaken to record exacerbations and health resource use in patients with COPD during 6 months of treatment with tiotropium, salmeterol, or…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Reducing cholinergic constriction: the major reversible mechanism in COPD by Brusasco, V

    Published in European respiratory review (01-12-2006)
    “…CORRESPONDENCE: V. Brusasco, Departimento di Medicina Interna, Università di Genova, Viale Benedetto XV 6, 16132 Genova, Italy. Fax: 39 103537690. E-mail:…”
    Get full text
    Journal Article
  11. 11

    Revisited role for mucus hypersecretion in the pathogenesis of COPD by Cerveri, I, Brusasco, V

    Published in European respiratory review (01-06-2010)
    “…Chronic obstructive pulmonary disease (COPD) is a heterogeneous and complex disease of which the basic pathophysiological mechanisms remain largely unknown. On…”
    Get full text
    Journal Article
  12. 12

    Beclomethasone/formoterol in the management of COPD: A randomised controlled trial by Calverley, P.M.A, Kuna, P, Monsó, E, Costantini, M, Petruzzelli, S, Sergio, F, Varoli, G, Papi, A, Brusasco, V

    Published in Respiratory medicine (01-12-2010)
    “…Summary Objectives To evaluate the effect of beclomethasone/formoterol versus budesonide/formoterol (non-inferiority) and versus formoterol (superiority) in…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20